XML 15 R4.htm IDEA: XBRL DOCUMENT v3.25.1
Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) (Unaudited) - USD ($)
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Income Statement [Abstract]    
Revenues $ 3,649,410 $ 3,894,447
Cost of sales 1,515,592 1,940,025
Gross Profit 2,133,818 1,954,422
Operating expenses:    
General and administrative 1,972,811 2,682,658
Research and development 736,411 1,130,229
Sales and marketing 427,141 535,423
Total operating expenses 3,136,363 4,348,310
Loss from operations (1,002,545) (2,393,888)
Other income (expense):    
Interest expense (57,529) (3,785,344)
Gain on change in fair value of warrant liabilities 7,780,000
Gain (loss) on disposal of fixed assets (13,988)
Other income (expense), net 340,113 (122,367)
Total other income (expense), net 8,062,584 (3,921,699)
Net income (loss) before provision for income taxes 7,060,039 (6,315,587)
Provision for income taxes
Net income (loss) 7,060,039 (6,315,587)
Accrued dividends on Series F Preferred Stock (67,651) (61,235)
Deemed dividends on Series F Preferred Stock and Warrants (1,056,332) (5,249,704)
Net income (loss) attributable to common stockholders $ 5,936,056 $ (11,626,526)
Net income (loss) per common share - Basic $ 0.51 $ (70.50)
Net loss per common share - Diluted $ (0.09) $ (70.50)
Weighted average number of shares outstanding during the period – Basic [1] 11,649,682 164,915
Weighted average number of shares outstanding during the period – Diluted [1] 20,194,461 164,915
Comprehensive income (loss):    
Amortization of unrecognized periodic pension costs $ 107,565
Foreign currency cumulative translation adjustment (21,779) (163,653)
Total comprehensive income (loss), net of tax $ 7,145,825 $ (6,479,240)
[1] Adjusted for the effect of a 1 to 50 reverse stock split that became effective on October 14, 2024 (see Note 1)